about
Metastatic colorectal cancer presenting with bone marrow metastasis: a case series and review of literatureDual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal CancersEvolving treatment approaches for the management of metastatic castration-resistant prostate cancer - role of radium-223Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature.Sunitinib Induced Thrombotic Thrombocytopenic Purpura in addition to Severe Hypothyroidism: A Case Report and Review of the Literature.Proportion of cancer in a Middle eastern country attributable to established risk factorsYounger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort.Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis.Breast cancer in low- and middle-income countries: an emerging and challenging epidemic.Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient.Sequencing of treatment in metastatic colorectal cancer: where to fit the targetCancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018.Angiogenesis and anti-angiogenic therapy in prostate cancer.Potential targets for colorectal cancer prevention.Methods of overcoming treatment resistance in colorectal cancer.Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.Iron overload and chelation therapy in myelodysplastic syndromes.Direct oral anticoagulants in the prevention of venous thromboembolism: evidence from major clinical trials.The value of inhibitors of factor Xa for the treatment of pulmonary embolism.B-type proto-oncogene-mutated tumors of colon cancer: promising therapeutic approaches.Programmed Death-Ligand 1 Expression in Muscle-Invasive Bladder Cancer Cystectomy Specimens and Lymph Node Metastasis: A Reliable Treatment Selection Biomarker?Cardiac and vascular toxicities of angiogenesis inhibitors: The other side of the coin.Prostate Cancer in the Arab World: A View From the Inside.New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer.Trends in lung cancer incidence in Lebanon by gender and histological type over the period 2005-2008.Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis.Dual targeting of HER3 and EGFR in colorectal tumors might overcome anti-EGFR resistance.Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective AnalysisPerceptions and Attitudes of Cancer Patients and Caregivers Towards Enrollment in Clinical Trials in Lebanon.Anxiety, Depression and Quality of Life in Breast Cancer Patients in the LevantPrevalence and Severity of Sleep Disturbances among Patients with Early Breast Cancer.A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.Simultaneous occurrence of a CD30 positive/ALK-negative high grade T-cell lymphoma and plasma cell myeloma: Report of a case.Increase in spleen volume as a predictor of oxaliplatin toxicity.Primary synovial sarcoma of the kidney: a case report of complete pathological response at a Lebanese tertiary care center.Could sodium imbalances predispose to postoperative venous thromboembolism? An analysis of the NSQIP database.Ki67 and P53 in Relation to Disease Progression in Metastatic Pancreatic Cancer: a Single Institution AnalysisAscorbic Acid in Colon Cancer: From the Basic to the Clinical ApplicationsThe unveiling of a new risk factor associated with bladder cancer in LebanonEMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence?
P50
Q26749022-399551BC-9972-42EF-A233-D0153A74B3E4Q26781362-8A65167F-3204-41EF-9FBD-8AB0B8C1C0EDQ26861575-6A77A448-A651-49AD-B8F9-D6F634A949A7Q30395541-1EB2025D-E248-44F0-BAB3-4D0FC059A6F5Q33418425-FAF0F1A4-597E-4340-A897-D0222F435122Q33706561-BBC09232-E6E8-4864-91DE-F15EEBD33F25Q33821156-77EBCED6-BBD3-4369-B1F2-C6E690077050Q34226276-3000AE07-28EF-43DA-B4E7-4063DDE3F36AQ34442719-1D68A4CA-C639-462E-ABE8-D0268DD81A9DQ36703169-1F445339-AB59-4F71-B228-401D75D27B14Q37602729-AE581C3C-D7AB-4868-927D-0F2811FAC11EQ37717216-810CACC8-8F50-4F9C-B3A6-14631D61CEB0Q38078609-A1F81A61-2819-4B1E-8B1B-48BAB3BDC01FQ38131401-528031F8-8EF2-4914-B920-EF2F923991DEQ38145938-A0DCACEB-CAA4-4FC7-9938-7800AF3E8659Q38148200-ABBF1420-68B7-4278-A576-B865FCA6CACEQ38188162-CD2A5A69-1867-4E02-B636-1C91D7252C77Q38214895-A1C66BD5-4FD5-42A2-A6E6-CB5572EF7C3EQ38215672-7DCC5C45-075F-4E6D-94D1-B60BA6CF209DQ38379642-8F4E4C4D-2027-42EE-89CD-4ABA7ABFAE7AQ38382624-0A33AADD-AE4C-410C-9AFD-548B7C5C3425Q38513838-D892A2BF-5878-436D-8F17-3A28729D054FQ38543348-320A20AB-970D-4B8C-9FAE-A8D40BAA5283Q38581586-C560344D-CF02-44F0-88C5-A56022AD7DFEQ38653104-BBD8B04B-75FE-49BD-8328-51A46746FD4BQ38703103-340C8FC9-B0A2-4B07-8128-82D475787A4CQ38790167-550C82EC-CF2A-4D74-8244-228A7FADCF4EQ41461334-A6748823-2528-4D9C-BB0A-489714228249Q47202558-C0BA8FFE-6EA0-41A6-A418-F738A8C7DD4FQ47233423-3F0F761E-8520-409C-8AD4-05459D949A8FQ49666191-F431B621-EC07-429E-B09C-EF091C0014B9Q54102824-E551220D-4A0F-4624-B568-4C4A09E90154Q54302721-7106FD5D-8FC0-462A-8232-A439F83F8945Q55077972-DD25A981-3597-4C26-B471-EEB12E7784B3Q55317841-1A0674C6-D634-4F76-8572-D6094BF561B0Q55455377-A9738A09-FD81-49FC-A1B4-D2A581FF4CCAQ56515170-AF9A961A-A837-4C2C-847E-9FC9039AF0FDQ58742334-310F76D9-9841-45F6-92AC-FC0D8B296833Q64061149-36ABD43A-31BC-496E-8026-5916DCDF71CEQ64107373-71E1206B-ADF0-4C3F-99B5-F9CB667CE0F7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sally Temraz
@en
Sally Temraz
@nl
type
label
Sally Temraz
@en
Sally Temraz
@nl
prefLabel
Sally Temraz
@en
Sally Temraz
@nl
P31
P496
0000-0002-8995-7946